(NASDAQ: TLRY) Tilray Brands's forecast annual revenue growth rate of 4.88% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 134.35%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.81%.
Tilray Brands's revenue in 2025 is $830,766,000.On average, 13 Wall Street analysts forecast TLRY's revenue for 2026 to be $98,938,842,498, with the lowest TLRY revenue forecast at $92,752,989,295, and the highest TLRY revenue forecast at $103,576,267,390. On average, 12 Wall Street analysts forecast TLRY's revenue for 2027 to be $103,401,100,736, with the lowest TLRY revenue forecast at $95,559,024,357, and the highest TLRY revenue forecast at $109,741,909,057.
In 2028, TLRY is forecast to generate $107,505,165,622 in revenue, with the lowest revenue forecast at $101,037,473,763 and the highest revenue forecast at $111,887,700,575.